Friday, July 10, 2026
🇺🇸 FDA

Drug profile · INN

hepatitis b surface antigen

HEPLISAV B

hepatitis b surface antigen (HEPLISAV B) is a surface antigen (hbsag) vaccine antigen.

EMA: approved Antiinfectives for systemic use (J07) J07BC01
Patents linked 13
Pipeline programs 2
News articles 0
Drug details — hepatitis b surface antigen
Class
Antiinfectives for systemic use (J07)
Route
—
Patents
13
Programs
2
Data quality
0.83
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

hepatitis b surface antigen (HEPLISAV B) is a surface antigen (hbsag) vaccine antigen.

Key facts

INN hepatitis b surface antigen
Brand HEPLISAV B
Mechanism Surface antigen (HBsAg) vaccine antigen
Target Surface antigen (HBsAg)
Therapeutic class Antiinfectives for systemic use (J07)
ATC code J07BC01

Mechanism of action

Surface antigen (HBsAg) vaccine antigen

Primary target: Surface antigen (HBsAg)

Approval history

Authority Status Date
EMA approved —

Pipeline programs

Search pipeline
  1. VBR Phase 2 · ASSEMBLY BIOSCIENCES · Chronic Hepatitis B
  2. Vebicorvir (VBR) Phase 1 · ASSEMBLY BIOSCIENCES · Chronic Hepatitis B

Related & competitor drugs

Browse all drugs
  1. atazanavir sulfate Antiinfectives for systemic use (J05)
  2. colistimethate sodium Antiinfectives for systemic use (J01)
  3. covid-19 mrna vaccine Antiinfectives for systemic use (J07)
  4. daptomycin Antiinfectives for systemic use (J01)
  5. darunavir Antiinfectives for systemic use (J05)
  6. dengue tetravalent vaccine (live, attenuated) Antiinfectives for systemic use (J07)

Related patents

Browse patents

  1. US 11814376

    Hepatitis b core protein modulators

    Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11331365

    Multispecific protein drug and library thereof, preparing method therefor and application thereof

    Expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11078170

    Cyclic sulfamide compounds and methods of using same

    Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11040965

    Process for making Hepatitis B core protein modulators

    Expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10987360

    Hepatitis B core protein modulators

    Expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10968211

    Hepatitis B core protein modulators

    Expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10947224

    Hepatitis B core protein allosteric modulators

    Expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10766890

    Hepatitis B core protein modulators

    Expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10392379

    Hepatitis B core protein modulators

    Expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10377748

    Hepatitis B core protein modulators

    Expires Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10273228

    Hepatitis B viral assembly effectors

    Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10183936

    Hepatitis B core protein allosteric modulators

    Expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 6254867

    Human monoclonal antibodies to the hepatitis B surface antigen

    Expires Mon Jun 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is hepatitis b surface antigen?

hepatitis b surface antigen (HEPLISAV B) is a surface antigen (hbsag) vaccine antigen.

What is the brand name for hepatitis b surface antigen?

HEPLISAV B is a marketed brand name for hepatitis b surface antigen. Check FDA Drugs@FDA for the current US label holder and prescribing information.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.